TrialInternational journal of hematology2015

A randomized controlled study evaluating the efficacy of aprepitant for highly/moderately emetogenic chemotherapies in hematological malignancies.

R Nasu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.